BASTEI LUBBE AG (BST.DE) Fundamental Analysis & Valuation

FRA:BSTDE000A1X3YY0

Current stock price

6.54 EUR
0 (0%)
Last:

This BST.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. BST.DE Profitability Analysis

1.1 Basic Checks

  • In the past year BST was profitable.
  • BST had a negative operating cash flow in the past year.
  • Each year in the past 5 years BST has been profitable.
  • BST had a positive operating cash flow in 4 of the past 5 years.
BST.DE Yearly Net Income VS EBIT VS OCF VS FCFBST.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M

1.2 Ratios

  • The Return On Assets of BST (7.78%) is better than 92.31% of its industry peers.
  • Looking at the Return On Equity, with a value of 13.88%, BST is in the better half of the industry, outperforming 78.46% of the companies in the same industry.
  • BST has a Return On Invested Capital of 11.80%. This is amongst the best in the industry. BST outperforms 87.69% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BST is above the industry average of 7.84%.
  • The last Return On Invested Capital (11.80%) for BST is above the 3 year average (11.74%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.78%
ROE 13.88%
ROIC 11.8%
ROA(3y)7.31%
ROA(5y)8.15%
ROE(3y)12.63%
ROE(5y)15.01%
ROIC(3y)11.74%
ROIC(5y)11.8%
BST.DE Yearly ROA, ROE, ROICBST.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • The Profit Margin of BST (8.23%) is better than 81.54% of its industry peers.
  • In the last couple of years the Profit Margin of BST has declined.
  • BST has a better Operating Margin (11.41%) than 70.77% of its industry peers.
  • BST's Operating Margin has improved in the last couple of years.
  • BST's Gross Margin of 51.60% is in line compared to the rest of the industry. BST outperforms 53.85% of its industry peers.
  • BST's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.41%
PM (TTM) 8.23%
GM 51.6%
OM growth 3Y5.11%
OM growth 5Y25.16%
PM growth 3Y-4.99%
PM growth 5YN/A
GM growth 3Y1.19%
GM growth 5Y3.74%
BST.DE Yearly Profit, Operating, Gross MarginsBST.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

5

2. BST.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BST is still creating some value.
  • The number of shares outstanding for BST remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, BST has about the same amount of shares outstanding.
  • Compared to 1 year ago, BST has an improved debt to assets ratio.
BST.DE Yearly Shares OutstandingBST.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
BST.DE Yearly Total Debt VS Total AssetsBST.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M

2.2 Solvency

  • An Altman-Z score of 2.84 indicates that BST is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • BST has a Altman-Z score of 2.84. This is amongst the best in the industry. BST outperforms 90.77% of its industry peers.
  • BST has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.05, BST belongs to the top of the industry, outperforming 83.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 2.84
ROIC/WACC1.65
WACC7.13%
BST.DE Yearly LT Debt VS Equity VS FCFBST.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

  • BST has a Current Ratio of 1.46. This is a normal value and indicates that BST is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BST (1.46) is better than 75.38% of its industry peers.
  • BST has a Quick Ratio of 1.07. This is a normal value and indicates that BST is financially healthy and should not expect problems in meeting its short term obligations.
  • BST's Quick ratio of 1.07 is fine compared to the rest of the industry. BST outperforms 67.69% of its industry peers.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.07
BST.DE Yearly Current Assets VS Current LiabilitesBST.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

2

3. BST.DE Growth Analysis

3.1 Past

  • BST shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.98%.
  • The Earnings Per Share has been growing slightly by 1.14% on average over the past years.
  • The Revenue has decreased by -0.79% in the past year.
  • Measured over the past years, BST shows a small growth in Revenue. The Revenue has been growing by 6.95% on average per year.
EPS 1Y (TTM)-10.98%
EPS 3Y1.14%
EPS 5YN/A
EPS Q2Q%-32.37%
Revenue 1Y (TTM)-0.79%
Revenue growth 3Y6.45%
Revenue growth 5Y6.95%
Sales Q2Q%3.3%

3.2 Future

  • Based on estimates for the next years, BST will show a decrease in Earnings Per Share. The EPS will decrease by -1.18% on average per year.
  • BST is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.99% yearly.
EPS Next Y-9.69%
EPS Next 2Y0.19%
EPS Next 3Y-1.18%
EPS Next 5YN/A
Revenue Next Year2.05%
Revenue Next 2Y2.22%
Revenue Next 3Y2.2%
Revenue Next 5Y0.99%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BST.DE Yearly Revenue VS EstimatesBST.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M
BST.DE Yearly EPS VS EstimatesBST.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5

5

4. BST.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 10.55, the valuation of BST can be described as very reasonable.
  • Based on the Price/Earnings ratio, BST is valued a bit cheaper than 69.23% of the companies in the same industry.
  • BST is valuated cheaply when we compare the Price/Earnings ratio to 25.71, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 7.50 indicates a rather cheap valuation of BST.
  • 81.54% of the companies in the same industry are more expensive than BST, based on the Price/Forward Earnings ratio.
  • BST is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.83, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.55
Fwd PE 7.5
BST.DE Price Earnings VS Forward Price EarningsBST.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • BST's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. BST is cheaper than 61.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.74
BST.DE Per share dataBST.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • The decent profitability rating of BST may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.19%
EPS Next 3Y-1.18%

7

5. BST.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.50%, BST is a good candidate for dividend investing.
  • In the last 3 months the price of BST has falen by -24.31%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • BST's Dividend Yield is a higher than the industry average which is at 3.37.
  • Compared to an average S&P500 Dividend Yield of 1.91, BST pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.5%

5.2 History

  • On average, the dividend of BST grows each year by 156.54%, which is quite nice.
Dividend Growth(5Y)156.54%
Div Incr Years1
Div Non Decr Years1
BST.DE Yearly Dividends per shareBST.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

  • 50.46% of the earnings are spent on dividend by BST. This is a bit on the high side, but may be sustainable.
  • The Dividend Rate of BST has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP50.46%
EPS Next 2Y0.19%
EPS Next 3Y-1.18%
BST.DE Yearly Income VS Free CF VS DividendBST.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M 15M
BST.DE Dividend Payout.BST.DE Dividend Payout, showing the Payout Ratio.BST.DE Dividend Payout.PayoutRetained Earnings

BST.DE Fundamentals: All Metrics, Ratios and Statistics

BASTEI LUBBE AG

FRA:BST (3/13/2026, 7:00:00 PM)

6.54

0 (0%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)02-05
Earnings (Next)07-13
Inst Owners5.35%
Inst Owner ChangeN/A
Ins Owners39.08%
Ins Owner ChangeN/A
Market Cap86.98M
Revenue(TTM)115.55M
Net Income(TTM)9.42M
Analysts87.5
Price Target12.39 (89.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.5%
Yearly Dividend0.3
Dividend Growth(5Y)156.54%
DP50.46%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.18%
PT rev (3m)-6.18%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.32%
EPS NY rev (3m)-3.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.36%
Revenue NY rev (3m)-1.36%
Valuation
Industry RankSector Rank
PE 10.55
Fwd PE 7.5
P/S 0.76
P/FCF N/A
P/OCF N/A
P/B 1.28
P/tB 1.42
EV/EBITDA 5.74
EPS(TTM)0.62
EY9.48%
EPS(NY)0.87
Fwd EY13.33%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.47
OCFYN/A
SpS8.6
BVpS5.1
TBVpS4.6
PEG (NY)N/A
PEG (5Y)N/A
Graham Number8.44
Profitability
Industry RankSector Rank
ROA 7.78%
ROE 13.88%
ROCE 17.42%
ROIC 11.8%
ROICexc 12.87%
ROICexgc 14.25%
OM 11.41%
PM (TTM) 8.23%
GM 51.6%
FCFM N/A
ROA(3y)7.31%
ROA(5y)8.15%
ROE(3y)12.63%
ROE(5y)15.01%
ROIC(3y)11.74%
ROIC(5y)11.8%
ROICexc(3y)15.22%
ROICexc(5y)15.52%
ROICexgc(3y)17.65%
ROICexgc(5y)18.64%
ROCE(3y)17.34%
ROCE(5y)17.43%
ROICexgc growth 3Y-3.07%
ROICexgc growth 5Y16.83%
ROICexc growth 3Y1.69%
ROICexc growth 5Y15.18%
OM growth 3Y5.11%
OM growth 5Y25.16%
PM growth 3Y-4.99%
PM growth 5YN/A
GM growth 3Y1.19%
GM growth 5Y3.74%
F-Score3
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA 0.24
Cap/Depr 73.65%
Cap/Sales 1.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 1.07
Altman-Z 2.84
F-Score3
WACC7.13%
ROIC/WACC1.65
Cap/Depr(3y)46.32%
Cap/Depr(5y)34.22%
Cap/Sales(3y)1.19%
Cap/Sales(5y)0.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-10.98%
EPS 3Y1.14%
EPS 5YN/A
EPS Q2Q%-32.37%
EPS Next Y-9.69%
EPS Next 2Y0.19%
EPS Next 3Y-1.18%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.79%
Revenue growth 3Y6.45%
Revenue growth 5Y6.95%
Sales Q2Q%3.3%
Revenue Next Year2.05%
Revenue Next 2Y2.22%
Revenue Next 3Y2.2%
Revenue Next 5Y0.99%
EBIT growth 1Y-16.35%
EBIT growth 3Y11.89%
EBIT growth 5Y33.86%
EBIT Next Year-3.75%
EBIT Next 3Y4.01%
EBIT Next 5YN/A
FCF growth 1Y-228.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-193.21%
OCF growth 3YN/A
OCF growth 5YN/A

BASTEI LUBBE AG / BST.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BASTEI LUBBE AG (BST.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to BST.DE.


What is the valuation status of BASTEI LUBBE AG (BST.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to BASTEI LUBBE AG (BST.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for BASTEI LUBBE AG?

BASTEI LUBBE AG (BST.DE) has a profitability rating of 7 / 10.


What is the valuation of BASTEI LUBBE AG based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BASTEI LUBBE AG (BST.DE) is 10.55 and the Price/Book (PB) ratio is 1.28.


How financially healthy is BASTEI LUBBE AG?

The financial health rating of BASTEI LUBBE AG (BST.DE) is 5 / 10.